Allogeneic cell therapy: The treatment of choice for all hematologic malignancies relapsing post BMT [2]

Blood

Volumn 87, Issue 9, 1996, Pages 4011-4013

  Slavin, S ^a   Naparstek, E ^a   Nagler, A ^a   Kapelushnik, Y ^a   Ackerstein, A ^a   Or, R ^a   Kolb, H J ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOPTIVE IMMUNOTHERAPY; ADOPTIVE TRANSFER; ALLOGENEIC RESTRICTION; BONE MARROW TRANSPLANTATION; CANCER RECURRENCE; CASE REPORT; CHILD; HEMATOLOGIC DISEASE; HUMAN; LETTER; LYMPHOCYTE; MALE; PRIORITY JOURNAL;

EID: 0029875481     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v87.9.4011.bloodjournal8794011     Document Type: Letter

References (0)